Analysis of the frequency of vascular comorbidity in patients with recurrent acute stroke
ARTICLE PDF (Українська)

Keywords

stroke, hypertension, comorbidity, risk factors

How to Cite

Mikitey, O. N., Svyrydova, N. K., & Pavliuk, N. P. (2015). Analysis of the frequency of vascular comorbidity in patients with recurrent acute stroke. East European Journal of Neurology, (6(6), 45-49. https://doi.org/10.33444/2411-5797.2015.6(6).45-49

Abstract

Stroke is an important medical and social problem, which occupies the second place in the population figures for mortality and one of the first rate for disability. Given the magnitude of the incidence, severity, effects, high incidence of recurrence great importance becomes its primary and secondary prevention that provides impact on the risk factors: high blood pressure, diabetes, high cholesterol, atrial fibrillation, sickle-cell anemia, open oval window, alcoholism. Prognosis depends on many factors, primarily on the amount and location of lesions of the brain, the severity of comorbidity and the patient’s age.

https://doi.org/10.33444/2411-5797.2015.6(6).45-49
ARTICLE PDF (Українська)

References

1. Леськив Е.Б. Использование блокатора ангиотен- зина ІІ для вторичной профилактики наруше- ний мозгового кровообращения /Леськив Е.Б., Хабазня Т.Ф. // Муждународный неврологиче- ский журнал.- 2010.-№3 (33). – С.34-39
2. Карнацевич Ю.С. Повторный инсульт - прогно- зирование и профилактика/ Карнацевич Ю. С. // Медицинский журнал. - 2005. - № 4. - С. 61-65.
3. 2015 AHA/ASA Guidelines for the Prevention of Stroke in Women A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association/[Cheryl Bushnell, Louise D. McCullough, Issam A. Awad et al.]. – 2015. – P. 1-45.
4. Румянцева С.А. Оценка реабилитационного потенциала у коморбидных больных с инсуль- том / Румянцева С.А., Силина Е.В., Юрлова А.С., Болевич С.Б. // Вестник восстановительной медицины. – 2014. – №3. – С. 91-92.
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.